Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2024 Filed Sep 17, 2024 16:05 UTC |
Poletti FrancoPresident, Cardiopulmonary
|
GrantPerformance Stock Units · Derivative | 1,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000123 · wk-form4_1726603520.xml · derivative · entry 2 Poletti Franco · CIK 0002031281 · President, Cardiopulmonary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,287 Underlying: Ordinary Shares · 1,287 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Plan and the award agreement. F4 · derivative.exercise_date: On September 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow ("FCF") for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F4 · derivative.expiration_date: On September 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow ("FCF") for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| September 15, 2024 Filed Sep 17, 2024 16:05 UTC |
Poletti FrancoPresident, Cardiopulmonary
|
GrantRestricted Stock Units · Derivative | 2,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000123 · wk-form4_1726603520.xml · derivative · entry 1 Poletti Franco · CIK 0002031281 · President, Cardiopulmonary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,575 Underlying: Ordinary Shares · 2,575 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of LivaNova PLC (the "Company"), GBP 1.00 par value, in accordance with the terms of the Company's 2022 Incentive Award Plan (the "Plan") and the award agreement. F2 · derivative.exercise_date: On September 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on September 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F2 · derivative.expiration_date: On September 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on September 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| September 11, 2024 Filed Sep 13, 2024 20:13 UTC |
Bianchi FrancescoDirector
|
SaleOrdinary Shares | 1,500 | $46.58 | $69,870.00 |
DisclosureSEC source: 0001639691-24-000119 · wk-form4_1726258430.xml · nonDerivative · entry 1 Bianchi Francesco · CIK 0001656080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,772 Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
Tezel AhmetChief Innovation Officer
|
GrantStock Appreciation Rights · Derivative | 25,383 | $0.00 Strike: $52.68 | $0.00 |
DisclosureSEC source: 0001639691-24-000098 · wk-form4_1718741187.xml · derivative · entry 5 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,383 Underlying: Ordinary Shares · 25,383 shares Expires 2034-06-15 F7 · derivative.exercise_date: On June 15, 2024, reporting person was granted stock appreciation rights ("SARs") subject to a four-year vesting in equal annual installments, the first vesting occurring on June 15, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
Tezel AhmetChief Innovation Officer
|
GrantPerformance Stock Units · Derivative | 7,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000098 · wk-form4_1718741187.xml · derivative · entry 4 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,118 Underlying: Ordinary Shares · 7,118 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Plan and the award agreement. F6 · derivative.exercise_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return ("TSR") for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F6 · derivative.expiration_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return ("TSR") for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
Tezel AhmetChief Innovation Officer
|
GrantPerformance Stock Units · Derivative | 3,559 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000098 · wk-form4_1718741187.xml · derivative · entry 3 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,559 Underlying: Ordinary Shares · 3,559 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Plan and the award agreement. F5 · derivative.exercise_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital ("ROIC") calculated for the performance period 2024-2026 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F5 · derivative.expiration_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital ("ROIC") calculated for the performance period 2024-2026 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
Tezel AhmetChief Innovation Officer
|
GrantPerformance Stock Units · Derivative | 3,559 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000098 · wk-form4_1718741187.xml · derivative · entry 2 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,559 Underlying: Ordinary Shares · 3,559 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Plan and the award agreement. F4 · derivative.exercise_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow ("FCF") for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F4 · derivative.expiration_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow ("FCF") for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
Tezel AhmetChief Innovation Officer
|
GrantRestricted Stock Units · Derivative | 11,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000098 · wk-form4_1718741187.xml · derivative · entry 1 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,863 Underlying: Ordinary Shares · 11,863 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of LivaNova PLC ("the Company") GBP 1.00 par value in accordance with the terms of the Company's 2022 Incentive Award Plan ("the Plan") and the award agreement. F2 · derivative.exercise_date: On June 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on June 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F2 · derivative.expiration_date: On June 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on June 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:05 UTC |
Story BrookeDirector
|
GrantRestricted Stock Units · Derivative | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000091 · wk-form4_1718741098.xml · derivative · entry 4 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,416 Underlying: Ordinary Shares · 3,416 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. F5 · derivative.exercise_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. F5 · derivative.expiration_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:05 UTC |
Story BrookeDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000091 · wk-form4_1718741098.xml · derivative · entry 3 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. F4 · derivative.exercise_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024. F4 · derivative.expiration_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:05 UTC |
Story BrookeDirector
|
Tax withholdingOrdinary Shares | 584 | $52.68 | $30,765.12 |
DisclosureSEC source: 0001639691-24-000091 · wk-form4_1718741098.xml · nonDerivative · entry 2 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,476 F3 · shares: The referenced shares were withheld from distribution to satisfy tax liability. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:05 UTC |
Story BrookeDirector
|
Exercise / conversionOrdinary Shares | 2,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000091 · wk-form4_1718741098.xml · nonDerivative · entry 1 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") settled into ordinary shares of LivaNova PLC ("the Company"), GBP 1.00 par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
Barry James ChristopherDirector
|
GrantRestricted Stock Units · Derivative | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000100 · wk-form4_1718741210.xml · derivative · entry 1 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,416 Underlying: Ordinary Shares · 3,416 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. F2 · derivative.exercise_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. F2 · derivative.expiration_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
WILVER PETER MDirector
|
GrantRestricted Stock Units · Derivative | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000099 · wk-form4_1718741198.xml · derivative · entry 4 WILVER PETER M · CIK 0001234537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,416 Underlying: Ordinary Shares · 3,416 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. F5 · derivative.exercise_date: The RSUS vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. F5 · derivative.expiration_date: The RSUS vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
WILVER PETER MDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000099 · wk-form4_1718741198.xml · derivative · entry 3 WILVER PETER M · CIK 0001234537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. F4 · derivative.exercise_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024. F4 · derivative.expiration_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
WILVER PETER MDirector
|
Tax withholdingOrdinary Shares | 585 | $52.68 | $30,817.80 |
DisclosureSEC source: 0001639691-24-000099 · wk-form4_1718741198.xml · nonDerivative · entry 2 WILVER PETER M · CIK 0001234537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,732 F3 · shares: The referenced shares were withheld from distribution to satisfy tax liability. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
WILVER PETER MDirector
|
Exercise / conversionOrdinary Shares | 2,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000099 · wk-form4_1718741198.xml · nonDerivative · entry 1 WILVER PETER M · CIK 0001234537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") settled into ordinary shares of LivaNova PLC ("the Company"), GBP 1.00 par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:05 UTC |
KOZY WILLIAM ADirector
|
GrantRestricted Stock Units · Derivative | 4,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000093 · wk-form4_1718741130.xml · derivative · entry 1 KOZY WILLIAM A · CIK 0001221785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,840 Underlying: Ordinary Shares · 4,840 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. F2 · derivative.exercise_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. F2 · derivative.expiration_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:05 UTC |
SCHERMERHORN TODD CDirector
|
GrantRestricted Stock Units · Derivative | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000094 · wk-form4_1718741141.xml · derivative · entry 4 SCHERMERHORN TODD C · CIK 0001204654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,416 Underlying: Ordinary Shares · 3,416 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. F5 · derivative.exercise_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. F5 · derivative.expiration_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:05 UTC |
SCHERMERHORN TODD CDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000094 · wk-form4_1718741141.xml · derivative · entry 3 SCHERMERHORN TODD C · CIK 0001204654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. F4 · derivative.exercise_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024. F4 · derivative.expiration_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:05 UTC |
SCHERMERHORN TODD CDirector
|
Tax withholdingOrdinary Shares | 586 | $52.68 | $30,870.48 |
DisclosureSEC source: 0001639691-24-000094 · wk-form4_1718741141.xml · nonDerivative · entry 2 SCHERMERHORN TODD C · CIK 0001204654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,057 F3 · shares: The referenced shares were withheld from distribution to satisfy tax liability. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:05 UTC |
SCHERMERHORN TODD CDirector
|
Exercise / conversionOrdinary Shares | 2,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000094 · wk-form4_1718741141.xml · nonDerivative · entry 1 SCHERMERHORN TODD C · CIK 0001204654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") settled into ordinary shares of LivaNova PLC ("the Company"), GBP 1.00 par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
Enxing Seng StacyDirector
|
GrantRestricted Stock Units · Derivative | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000097 · wk-form4_1718741176.xml · derivative · entry 4 Enxing Seng Stacy · CIK 0001329921 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,416 Underlying: Ordinary Shares · 3,416 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. F5 · derivative.exercise_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. F5 · derivative.expiration_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
Enxing Seng StacyDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000097 · wk-form4_1718741176.xml · derivative · entry 3 Enxing Seng Stacy · CIK 0001329921 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. F4 · derivative.exercise_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024. F4 · derivative.expiration_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
Enxing Seng StacyDirector
|
Tax withholdingOrdinary Shares | 585 | $52.68 | $30,817.80 |
DisclosureSEC source: 0001639691-24-000097 · wk-form4_1718741176.xml · nonDerivative · entry 2 Enxing Seng Stacy · CIK 0001329921 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,745 F3 · shares: The referenced shares were withheld from distribution to satisfy tax liability. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
Enxing Seng StacyDirector
|
Exercise / conversionOrdinary Shares | 2,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000097 · wk-form4_1718741176.xml · nonDerivative · entry 1 Enxing Seng Stacy · CIK 0001329921 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,330 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") settled into ordinary shares of LivaNova PLC ("the Company"), GBP 1.00 par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC | Exercise / conversionRestricted Stock Units · Derivative | 1,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000096 · wk-form4_1718741164.xml · derivative · entry 3 Shvartsburg Alex · CIK 0001830830 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,576 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ('the Plan') and the award agreement. F4 · derivative.exercise_date: On June 15, 2020, reporting person was granted RSUs subject to a four-year vesting schedule, the final vesting for which occurred June 15, 2024. F4 · derivative.expiration_date: On June 15, 2020, reporting person was granted RSUs subject to a four-year vesting schedule, the final vesting for which occurred June 15, 2024. Read SEC document |
|
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC | Tax withholdingOrdinary Shares | 670 | $52.68 | $35,295.60 |
DisclosureSEC source: 0001639691-24-000096 · wk-form4_1718741164.xml · nonDerivative · entry 2 Shvartsburg Alex · CIK 0001830830 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,729 F3 · shares: The referenced shares were withheld from distribution to satisfy tax liability. Read SEC document |
|
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC | Exercise / conversionOrdinary Shares | 1,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000096 · wk-form4_1718741164.xml · nonDerivative · entry 1 Shvartsburg Alex · CIK 0001830830 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,399 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ('RSUs') settled into ordinary shares of LivaNova PLC ('the Company'), GBP 1.00 par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ('the Plan') and the award agreement. Read SEC document |
|
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
Bianchi FrancescoDirector
|
GrantRestricted Stock Units · Derivative | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000095 · wk-form4_1718741153.xml · derivative · entry 4 Bianchi Francesco · CIK 0001656080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,416 Underlying: Ordinary Shares · 3,416 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. F5 · derivative.exercise_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. F5 · derivative.expiration_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
Bianchi FrancescoDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000095 · wk-form4_1718741153.xml · derivative · entry 3 Bianchi Francesco · CIK 0001656080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. F4 · derivative.exercise_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024. F4 · derivative.expiration_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
Bianchi FrancescoDirector
|
Tax withholdingOrdinary Shares | 585 | $52.68 | $30,817.80 |
DisclosureSEC source: 0001639691-24-000095 · wk-form4_1718741153.xml · nonDerivative · entry 2 Bianchi Francesco · CIK 0001656080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,272 F3 · shares: The referenced shares were withheld from distribution to satisfy tax liability. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC |
Bianchi FrancescoDirector
|
Exercise / conversionOrdinary Shares | 2,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000095 · wk-form4_1718741153.xml · nonDerivative · entry 1 Bianchi Francesco · CIK 0001656080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") settled into ordinary shares of LivaNova PLC ("the Company"), GBP 1.00 par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:05 UTC |
O'Kane SharonDirector
|
GrantRestricted Stock Units · Derivative | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000092 · wk-form4_1718741119.xml · derivative · entry 4 O'Kane Sharon · CIK 0001655980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,416 Underlying: Ordinary Shares · 3,416 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. F5 · derivative.exercise_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. F5 · derivative.expiration_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:05 UTC |
O'Kane SharonDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000092 · wk-form4_1718741119.xml · derivative · entry 3 O'Kane Sharon · CIK 0001655980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. F4 · derivative.exercise_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024. F4 · derivative.expiration_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:05 UTC |
O'Kane SharonDirector
|
Tax withholdingOrdinary Shares | 1,260 | $52.68 | $66,376.80 |
DisclosureSEC source: 0001639691-24-000092 · wk-form4_1718741119.xml · nonDerivative · entry 2 O'Kane Sharon · CIK 0001655980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,494 F3 · shares: The referenced shares were withheld from distribution to satisfy tax liability. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:05 UTC |
O'Kane SharonDirector
|
Exercise / conversionOrdinary Shares | 2,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000092 · wk-form4_1718741119.xml · nonDerivative · entry 1 O'Kane Sharon · CIK 0001655980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") settled into ordinary shares of LivaNova PLC ("the Company"), GBP 1.00 par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 16:03 UTC |
Moore Daniel JeffreyDirector
|
Exercise / conversionOption to purchase shares · Derivative | 56,623 | $0.00 Strike: $57.39 | $0.00 |
DisclosureSEC source: 0001639691-24-000072 · wk-form4_1717617811.xml · derivative · entry 4 Moore Daniel Jeffrey · CIK 0001400857 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 56,623 shares Expires 2024-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of the option occurred pursuant to a Rule 10b5-1 Plan adopted by reporting person on May 25, 2021. F5 · derivative.expiration_date: The Form 3 filed on behalf of the reporting person on October 22, 2015 contained a typo in the expiration date for this option. This option expires on June 15, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 16:03 UTC |
Moore Daniel JeffreyDirector
|
SaleOrdinary Shares | 2,045 | $61.09 | $124,920.87 |
DisclosureSEC source: 0001639691-24-000072 · wk-form4_1717617811.xml · nonDerivative · entry 3 Moore Daniel Jeffrey · CIK 0001400857 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,534 F2 · kind: The sale of the ordinary shares occurred pursuant to a Rule 10b5-1 Plan adopted by reporting person on May 25, 2021. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.829 to $61.290, inclusive. The reporting person undertakes to provide to LivaNova PLC, any security holder of LivaNova PLC, or the staff of the Securities and Exchange Commission, upon request, the information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 16:03 UTC |
Moore Daniel JeffreyDirector
|
SaleOrdinary Shares | 54,578 | $60.08 | $3,278,773.35 |
DisclosureSEC source: 0001639691-24-000072 · wk-form4_1717617811.xml · nonDerivative · entry 2 Moore Daniel Jeffrey · CIK 0001400857 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,579 F2 · kind: The sale of the ordinary shares occurred pursuant to a Rule 10b5-1 Plan adopted by reporting person on May 25, 2021. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.75 to $60.610, inclusive. The reporting person undertakes to provide to LivaNova PLC, any security holder of LivaNova PLC, or the staff of the Securities and Exchange Commission, upon request, the information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 16:03 UTC |
Moore Daniel JeffreyDirector
|
Exercise / conversionOrdinary Shares | 56,623 | $57.39 | $3,249,593.97 |
DisclosureSEC source: 0001639691-24-000072 · wk-form4_1717617811.xml · nonDerivative · entry 1 Moore Daniel Jeffrey · CIK 0001400857 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of the option occurred pursuant to a Rule 10b5-1 Plan adopted by reporting person on May 25, 2021. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:20 UTC |
Makatsaria VladimirDirector · Chief Executive Officer
|
GrantStock Appreciation Rights · Derivative | 29,309 | $0.00 Strike: $55.94 | $0.00 |
DisclosureSEC source: 0001639691-24-000046 · wk-form4_1712107241.xml · derivative · entry 7 Makatsaria Vladimir · CIK 0002012645 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,309 Underlying: Ordinary Shares · 29,309 shares Expires not disclosed F7 · derivative.exercise_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F7 · derivative.expiration_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:20 UTC |
Makatsaria VladimirDirector · Chief Executive Officer
|
GrantStock Appreciation Rights · Derivative | 52,268 | $0.00 Strike: $55.94 | $0.00 |
DisclosureSEC source: 0001639691-24-000046 · wk-form4_1712107241.xml · derivative · entry 6 Makatsaria Vladimir · CIK 0002012645 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,268 Underlying: Ordinary Shares · 52,268 shares Expires not disclosed F7 · derivative.exercise_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F7 · derivative.expiration_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:20 UTC |
Makatsaria VladimirDirector · Chief Executive Officer
|
GrantPerformance Stock Units · Derivative | 23,909 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000046 · wk-form4_1712107241.xml · derivative · entry 5 Makatsaria Vladimir · CIK 0002012645 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,909 Underlying: Ordinary Shares · 23,909 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement. F6 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F6 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:20 UTC |
Makatsaria VladimirDirector · Chief Executive Officer
|
GrantPerformance Stock Units · Derivative | 11,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000046 · wk-form4_1712107241.xml · derivative · entry 4 Makatsaria Vladimir · CIK 0002012645 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,954 Underlying: Ordinary Shares · 11,954 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement. F5 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2024-2026 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F5 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2024-2026 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:20 UTC |
Makatsaria VladimirDirector · Chief Executive Officer
|
GrantPerformance Stock Units · Derivative | 11,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000046 · wk-form4_1712107241.xml · derivative · entry 3 Makatsaria Vladimir · CIK 0002012645 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,954 Underlying: Ordinary Shares · 11,954 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement. F4 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow (FCF) for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F4 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow (FCF) for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:20 UTC |
Makatsaria VladimirDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 23,909 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000046 · wk-form4_1712107241.xml · derivative · entry 2 Makatsaria Vladimir · CIK 0002012645 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,909 Underlying: Ordinary Shares · 23,909 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. F2 · derivative.exercise_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F2 · derivative.expiration_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:20 UTC |
Makatsaria VladimirDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 13,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000046 · wk-form4_1712107241.xml · derivative · entry 1 Makatsaria Vladimir · CIK 0002012645 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,407 Underlying: Ordinary Shares · 13,407 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. F2 · derivative.exercise_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F2 · derivative.expiration_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:22 UTC |
Bolton StephaniePresident, Global Epilepsy
|
GrantStock Appreciation Rights · Derivative | 10,746 | $0.00 Strike: $55.94 | $0.00 |
DisclosureSEC source: 0001639691-24-000049 · wk-form4_1712107347.xml · derivative · entry 14 Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,746 Underlying: Ordinary Shares · 10,746 shares Expires not disclosed F18 · derivative.exercise_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. F18 · derivative.expiration_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. Read SEC document |
| March 30, 2024 Filed Apr 2, 2024 21:22 UTC |
Bolton StephaniePresident, Global Epilepsy
|
GrantPerformance Stock Units · Derivative | 4,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000049 · wk-form4_1712107347.xml · derivative · entry 13 Bolton Stephanie · CIK 0002012558 · President, Global Epilepsy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,915 Underlying: Ordinary Shares · 4,915 shares Expires not disclosed F14 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement. F17 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's TSR for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F17 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's TSR for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.